You have 9 free searches left this month | for more free features.

City

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

NiKang Therapeutics, Inc. (1)

Collaborator

Pfizer (1)

Intervention

nkt2152 (1)

palbociclib (1)

sasanlimab (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

nkt2152

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting

ccRCC
+20 more

NKT2152
+2 more

(no location specified)

Jul 6, 2023